<DOC>
	<DOCNO>NCT00551538</DOCNO>
	<brief_summary>The purpose study determine twice-daily Lispro low mixture ( 75/25 ) result low post prandial blood glucose reading versus once-daily glargine plus oral diabetic medication .</brief_summary>
	<brief_title>24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine</brief_title>
	<detailed_description>The primary objective study test hypothesis twice daily insulin regimen consist insulin lispro ( mix 75/25 ) plus OAMs result low 2 hour postprandial plasma glucose , average across morning evening meal , compare daily insulin glargine plus OAMs bedtime follow 12 week treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Have type 2 diabetes Have inadequate overall glycemic control ( hemoglobin A1c great equal 7.0 % less equal 12.0 % ) within 4 week prior Visit 1 Have use : single multiple OAMs least 3 month immediately prior enter study , include metformin , sulfonylurea , meglitinides ( repaglinide , nateglinide ) , alpha glucosidase inhibitor ( acarbose , miglitol ) ; insulin ( twice daily ) least 3 month immediately prior enter study ; combination . Are great equal 21 less 80 year age As determined investigator , capable willing : comply prescribe diet medication regimen , perform self blood glucose monitoring , use patient diary require protocol , participate two 24 hour inpatient assessment Have use thiazolidinedione ( pioglitazone rosiglitazone ) 3 month prior entry study Are currently treat meglitinide without sulfonylurea Have know allergy intolerance insulin lispro mix 75/25 , insulin glargine , metformin Have plasma creatinine great equal 1.5 mg/dL ( male ) great equal 1.4 mg/dL ( female ) patient treat metformin ; great 2 mg/dL patient treated OAMs , determine local laboratory Have receive chronic ( lasting longer 2 week ) , systemic glucocorticoid therapy ( exclude topical inhale preparation ) within 4 week immediately prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Insulin</keyword>
	<keyword>Glargine</keyword>
	<keyword>Lispro</keyword>
</DOC>